Connect your AI

Phibro Animal Health PAHC Book value per share

Book value per share at other companies

ZoetisZTS

$7.65-26.3%

Elanco Animal Health Inc.ELAN

$12.85+0.9%

NeogenNEOG

$9.66-21.2%

Mirum Pharmaceuticals, Inc.MIRM

$4.12-13.6%

AmgenAMGN

$16.89+47.2%

Petco Health and Wellness Company, Inc.WOOF

$4.07+2.1%

Other financials

Income statement

Revenue$383.5M+10.3%

Gross profit$125.7M+20.2%

Operating income$44.7M+33.2%

Net income$24.0M+15.1%

EPS (diluted)$0.59+15.7%

Balance sheet

Cash & equivalents$54.9M-9.0%

Total debt$32.3M+27.8%

Total equity$361.8M+36.0%

Total assets$1.4B+9.7%

Cash flow

Operating cash flow$16.2M-62.4%

CapEx$15.3M+97.7%

Free cash flow$890.0K-97.5%

Valuation

Market cap$1.27B+31.4%

Enterprise value$1.25B+33.9%

P/E13.4×-17.1×

P/S0.9×0.0×

Profitability

Gross margin32.5%+0.9pp

Operating margin12%+4.0pp

Net margin6.3%+3.7pp

FCF margin0.9%-3.3pp

Returns & leverage

Return on equity30.3%+18.5pp

Debt / equity0.1×0.0×

Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

total stockholders equity/weighted shares diluted=$8.82

Based on the most recent quarter.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Phibro Animal Health's book value per share?: Phibro Animal Health (PAHC) reported book value per share of $8.82 in Q1 2026.
How has Phibro Animal Health's book value per share changed year-over-year?: Phibro Animal Health's book value per share increased by 34.9% year-over-year, from $6.53 to $8.82.
What is the long-term trend for Phibro Animal Health's book value per share?: Over 4 years (2021 to 2025), Phibro Animal Health's book value per share has grown at a 4.5% compound annual growth rate (CAGR), from $5.89 to $7.02.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.